Testing effectiveness (Phase 2)Study completedNCT00003551What this trial is testingAminocamptothecin in Treating Patients With Advanced or Recurrent Kidney CancerWho this might be right forKidney Cancer Emory University
Testing effectiveness (Phase 2)Study completedNCT00004203What this trial is testingOxaliplatin in Treating Patients With Metastatic Bladder CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter University of Chicago 20
Early research (Phase 1)Study completedNCT00098943What this trial is testingNGR-TNF in Treating Patients With Advanced Solid TumorsWho this might be right forColorectal CancerHead and Neck CancerKidney Cancer+1 more European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)Study completedNCT00422786What this trial is testingPhase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Thallion Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT00378703What this trial is testingBevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7 National Cancer Institute (NCI) 361
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)UnknownNCT00890110What this trial is testingAutologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With SunitinibWho this might be right forRenal Cell Cancer Hadassah Medical Organization 13
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Large-scale testing (Phase 3)Study completedNCT00018941What this trial is testingInterleukin-2 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT03866382What this trial is testingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsWho this might be right forBladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more National Cancer Institute (NCI) 314
Early research (Phase 1)WithdrawnNCT03189186What this trial is testingPhase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell CarcinomasWho this might be right forRenal Cell CarcinomaMetastatic Kidney Cancer University of California, Irvine
Very early researchStudy completedNCT00276835What this trial is testingGenistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Northwestern University 15
Early research (Phase 1)Study completedNCT00351949What this trial is testingIMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)Who this might be right forStage IV Renal Cell Carcinoma Immutep S.A.S. 24
Large-scale testing (Phase 3)Study completedNCT00003126What this trial is testingInterleukin-2 in Treating Patients With Stage III or Stage IV Kidney CancerWho this might be right forKidney Cancer Loyola University 69
Testing effectiveness (Phase 2)Study completedNCT00045487What this trial is testingErlotinib in Treating Patients With Advanced Kidney CancerWho this might be right forKidney Cancer The University of Texas Health Science Center at San Antonio 41
Post-approval studies (Phase 4)Study completedNCT03525834What this trial is testingSafety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.Who this might be right forRenal Angiomyolipoma Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT00039052What this trial is testingIntravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast CancerWho this might be right forBreast CancerKidney CancerLung Cancer Neurocrine Biosciences
Testing effectiveness (Phase 2)WithdrawnNCT03927248What this trial is testingPAC-1 for Treatment of Refractory, Metastatic Kidney CancerWho this might be right forMetastatic Renal Cell Carcinoma HealthPartners Institute
Testing effectiveness (Phase 2)Study completedNCT00077129What this trial is testingPaclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell CancerWho this might be right forKidney Cancer Eastern Cooperative Oncology Group 22
Testing effectiveness (Phase 2)UnknownNCT00293501What this trial is testingTinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By SurgeryWho this might be right forKidney Cancer University of Vermont 35